Results 301 to 310 of about 440,890 (382)

Glycogen depletion in astrocytes induces sex-dimorphic remodeling of astrocytic and synaptic structures with concomitant anxiety-like behaviors and maternal care deficits. [PDF]

Biol Sex Differ
Shi X, Zhu Y, Zhang Z, Ma N, He D, Wu Y, Dai Z, Qin X, Chen Y, Zhao Y, Zhang H, Huang J, Zhang H, Fan Z.   +13 more
europepmc   +1 more source

Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes

, 1994
Andrea Volterra, Davide Trotti, Cinzia Tromba, STEFANO FLORIDI, Giorgio Racagni   +4 more
openalex   +1 more source

Establishment of a novel alloxan‐induced rabbit model exhibiting unique diabetic retinal neuropathy features assessed via ERG + VEP

Animal Models and Experimental Medicine, EarlyView.
Study workflow. Neuroretinal changes were observed in alloxan‐induced diabetic rabbits, while the retinal vasculature remained unaffected, indicating the successful establishment of a diabetic neuroretinal model. Abstract Background Diabetic retinal neuropathy (DRN) leads to significant visual impairment; however, no existing animal model fully ...
Xinlu Li, Xiaojing Dong, Defei Feng, Han Hu, Bai Li, Zhongjian Liu, Wei He, Chenchen Huang, Zhizhou Shi, Yan Mei   +9 more
wiley   +1 more source

Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination.

, 1992
Sámuel Komoly, Lynn D. Hudson, H. deF. Webster, Carolyn A. Bondy   +3 more
openalex   +1 more source

Regional and Global Changes in Brain Structure 1‐Year Post Pediatric “Mild” Traumatic Brain Injury

Annals of Neurology, EarlyView.
Objective Despite the high prevalence of pediatric “mild” traumatic brain injury (pmTBI), very little is known about the long‐term effects of injury on brain structure and how injuries manifest in the context of dynamic and regionally specific neurodevelopmental changes. Methods Prospective study design characterizing long‐term effects of pmTBI on both
Upasana Nathaniel, Tracey V. Wick, Josef L. Ling, Jessica R. McQuaid, Divyasree Sasi Kumar, Samuel D. Miller, Jingshu Wu, Vadim Zotev, Timothy B. Meier, Harm J. van der Horn, John P. Phillips, Richard A. Campbell, Robert E. Sapien, Rahsan Keskin, Andrei A. Vakhtin, Andrew R. Mayer   +15 more
wiley   +1 more source

Reactive Astrocytes with Reduced Function of Glutamate Transporters in the <i>App</i>^NL-G-F Knock-in Mice. [PDF]

ACS Chem Neurosci
Srivastava I, Goikolea J, Ayberk Kaya T, Latorre-Leal M, Eroli F, Pereira Iglesias M, Álvarez-Jiménez L, Arroyo-García LE, Shimozawa M, Nilsson P, Fisahn A, Lindskog M, Maioli S, Loera-Valencia R.   +13 more
europepmc   +1 more source

Longitudinal Analysis of Neuroradiological Biomarkers for Fragile X‐Associated Tremor/Ataxia Syndrome and Implications for Clinical Trials

Annals of Neurology, EarlyView.
Objective The objective of this study was to show the capacity of structural brain magnetic resonance imaging (MRI) measures to serve as monitoring biomarkers for Fragile X‐Associated Tremor/Ataxia Syndrome (FXTAS). Methods From 2 longitudinal studies of male FMR1 premutation carriers, 2 brain MRI scans were selected from each participant, collected ...
David Hessl, Jun Yi Wang, Glenda Espinal, Ellery Santos, Flora Tassone, Randi J. Hagerman, Susan M. Rivera   +6 more
wiley   +1 more source

MiR-298 suppresses astrocytic NF-κB activity and neuroinflammation <i>via</i> targeting MyD88 in bone cancer pain. [PDF]

Korean J Pain
Liu M, Wang D, Yan Z, Zhou M.
europepmc   +1 more source

A migration stimulating factor for vascular endothelial cells is released by cultured astrocytes.

, 1990
Yasuki Ishizaki, Toshie Kanayasu, Sei‐itsu Murota   +2 more
openalex   +2 more sources

Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks

Annals of Neurology, EarlyView.
Objective The objective of this study was to evaluate the timing of change of Alzheimer's disease (AD) plasma biomarkers (Aβ42/Aβ40, p‐tau217, p‐tau181, GFAP, and NfL) from six different assay platforms, alongside established AD biomarkers, using amyloid and tau positron emission tomography (PET)‐based AD progression timelines.
Marta Milà‐Alomà, Duygu Tosun, Suzanne E. Schindler, Isabella Hausle, Kellen K. Petersen, Yan Li, Jeffrey L. Dage, Lei Du‐Cuny, Ziad S. Saad, Benjamin Saef, Gallen Triana‐Baltzer, David L. Raunig, Janaky Coomaraswamy, Michael Baratta, Emily A. Meyers, Yulia Mordashova, Carrie E. Rubel, Kyle Ferber, Hartmuth Kolb, Nicholas J. Ashton, Henrik Zetterberg, Erin G. Rosenbaugh, Martin Sabandal, Leslie M. Shaw, Anthony W. Bannon, William Z. Potter, for the Alzheimer's Disease Neuroimaging Initiative (ADNI), Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ and Phosphorylated Tau as Predictors of Amyloid and Tau Positivity in Alzheimer's Disease Project Team   +27 more
wiley   +1 more source